| Scientific Name |
Adalimumab
|
|---|---|
| Brand Name |
Humira
|
| Risk |
Safety information about risks of Tuberculosis (TB), Malignancies, Demyelinating disorders (including multiple sclerosis [MS], Guillain-Barré syndrome [GBS] and optic neuritis [ON]), BCG disease following live BCG vaccination in infants with in utero exposure to Humira.
|
| Safety Communication for Healthcare Professionals |
|
| Educational Materials for Patients |
|